Meningitis Study: Now Enrolling Children and Adults for Vaccine Study
Meningococcal disease (meningitis) is a serious illness that can spread when an infected person coughs or sneezes. Although meningitis incidence varies in different regions of the world, infants, children and adolescents are the most vulnerable to catching the disease. Symptoms of the disease occur quickly and often result in severe outcomes within a few hours; otherwise healthy individuals can be permanently disabled or die of the disease. The best way to protect against meningococcal disease and its spread is a vaccine.
Who Qualifies? We’re looking to enroll children and adults between 10 – 25 years old who are reasonably in good health.
What to Expect? Participants will be asked to come into the research clinic six times and be contacted by phone 10 times. Participants will receive compensation for time and travel. A child’s health as it relates to this study, will be evaluated at each appointment by the research coordinator and study doctor. All study procedures will be at no cost to the participant and will not be filed to the participant’s insurance. Our study team can coordinate with the participants primary care physician to help you receive the most individualized care from our Hattiesburg Clinic team.
Number of visits required: Six visits and 10 phone contacts.
Where will these visits be located? Hattiesburg Clinic MediSync® Clinical Research
206 Old Corinth Rd., Petal, MS 39465
To learn more, please call Hattiesburg Clinic MediSync® Clinical Research at (601) 544-1866. You may also click hereand fill out the “Contact Us” section to complete the research inquiry form.
Hattiesburg Clinic MediSync® Clinical Research is committed to providing new study opportunities to all the patients of Hattiesburg Clinic. Your quality of life through the advancement of medicine is what drives our research.